GlassScriptPhysician profile
Julie A Mccullough
NPI 1407802192
$1,285.54
in general payments reported to CMS, 2019-2025
12 companies · $482 in 2025
The $482 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $71.11 · 2021: $151 · 2023: $118 · 2024: $112 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $534.13 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $403.63 | 2019-2025 | Veozah |
| Abbvie INC. | $374.02 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $224.90 | 2025 | |
| Therapeuticsmd, INC. | $53.81 | 2019-2021 | |
| Avion Pharmaceuticals | $49.22 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.80 | 2025 | |
| Hologic Sales and Service, LLC | $28.09 | 2025 | Omni Hysteroscope |
| Organon LLC | $26.63 | 2025 | Nexplanon |
| Pfizer INC. | $24.93 | 2023 | |
| Lupin INC. | $19.04 | 2019 | |
| Amag Pharmaceuticals, INC. | $18.92 | 2019 | |
| Exeltis, USA INC. | $18.55 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Mccullough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.